Tg Therapeutics TGTX

$54.29 +0.67 (1.25%)

Valuation

Market cap
8,207,560,000
Revenue TTM
$616,290,000
Net income TTM
$447,180,000
PE ratio
19.99
Forward PE
60.85
Profit margin
72.56%
Debt to equity
1.23

Trading

Volume
1,650,400
Avg volume
2,049,698
Day's range
$53.15 – $54.98
Shares out
153,069,000
Stochastic %K
21%
Beta
1.80
Analysts
Sell
Price target
$63.00

Price

Company profile

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsin...

Show more

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Jiangsu Hengrui Medicine Co. The company was incorporated in 1993 and is based in Morrisville, North Carolina.

Industry
Biotechnology
Sector
Healthcare
Phone
212 554 4484
Website
https://www.tgtherapeutics.com
Address
3020 Carrington Mill Blvd., Suite 475, Morrisville, United States

Latest news

Stocktwits

OlDocAngus Oct 3, 6:29 PM
$TGTX Coming to America real, real soon so you’d better get ready! https://youtu.be/fJNKmfyXIak?is=-3pMqMNdbHQnMOME
0 replies
OlDocAngus Oct 3, 2:40 PM
$TGTX Everyday I read the news I instintively walk to my closet and conduct an inventory to see if I have enough weapons and ammo.
0 replies
OlDocAngus Oct 3, 2:30 PM
$TGTX Insanity on display. A parade of fools. https://modernity.news/2026/10/01/now-theyre-really-mad-7/
0 replies
OlDocAngus Oct 3, 2:22 PM
$TGTX Every last one of these savages should be rounded up and sent back to Africa. They are incompatible with a civilized society. https://modernity.news/2026/10/03/the-worst-ive-ever-seen/
0 replies
OlDocAngus Oct 3, 2:17 PM
$TGTX There is no such thing as “radical Islam.” There is only Islam. These jihadis who commit these acts are obeying the Quran to kill the infidel and all Jews and to die as martyrs. Anyone who believes differently has believed the propaganda of the western media and CAIR. Islam is a Satanically inspired cult. That is a fact whether you believe it or not. https://www.zerohedge.com/geopolitical/uae-says-omani-flydubai-co-pilot-attacked-captain-axe-tried-seize-israel-found-jet
0 replies
Notcharleshuggins Oct 3, 1:35 PM
$TGTX. Gentlemen, Should be a banging 3 months. October Ectrims Azer cel early data, 🟢, November earnings 🟢, December likely sub q data 🟢! And JPM in January. LFG
0 replies
OlDocAngus Oct 3, 1:08 PM
$TGTX AI is going to put a lot of analysts out of work. lol
0 replies
OlDocAngus Oct 3, 1:02 PM
$TGTX
0 replies